Becton Dickinson lands in Orange County the week of its Q2 earnings call

Becton Dickinson flew from Morristown Municipal Airport in New Jersey to John Wayne Airport in Orange County on June 19, arriving late that evening after a five-and-a-half-hour flight in its Falcon 7X. The trip comes just weeks after the company reported its fiscal second-quarter results for the period ending March 31, 2026, posting revenue of $4.7 billion and a 5.2% increase in reported growth, as detailed in its May 7 earnings release [investors.bd.com](https://investors.bd.com/news-events/press-releases/detail/958/bd-reports-second-quarter-fiscal-2026-financial-results).

The same week the company announced it had raised its full-year adjusted EPS guidance and reaffirmed revenue expectations, CEO Tom Polen noted on the earnings call that execution was “broad-based” and that more than 90% of the business delivered mid-single-digit growth. The flight to Orange County — a region dense with healthcare systems and life-science firms — likely aligns with ongoing commercial activity, including a strategic partnership with Wellstar Health System to advance AI-powered medication management at the bedside [sec.gov](https://www.sec.gov/Archives/edgar/data/10795/000162828026031638/ex9913312026.htm).

Becton Dickinson’s recent flight pattern shows frequent trips to Europe and the New York area, but this Southern California visit is a departure from its usual East Coast orbit. The company has been navigating regulatory headwinds, including a voluntary ship hold on ChloraPrep and PurPrep products in May, which it has since resumed shipping after additional testing cleared [investors.bd.com](https://investors.bd.com/sec-filings/all-sec-filings/content/0001628280-26-039005/0001628280-26-039005.pdf). The Orange County arrival suggests a focus on the West Coast’s dense hospital and biotech networks rather than a single headline event.